Australian Prescriber Podcast
Australian Prescriber
The Australian Prescriber Podcast provides a regular dive into some of the many great articles that Australian Prescriber publishes every two months. In each episode, our host will chat with one of the authors from a recent issue of Australian Prescriber.
Episodes
Mentioned books
May 28, 2018 • 8min
E25 – Antihistamines and allergy
Andrew Boyden interviews Dr Carolyn Hawkins about the use of antihistamines for managing allergy.
May 15, 2018 • 13min
E24 – Prescribing wellness: a better way to manage chronic pain
Ashlea Broomfield interviews Dr Newman Harris about the management of pain without opioids.
May 1, 2018 • 9min
E23 - 'Cephalosporin allergy' label is misleading
Dhineli Perera interviews Professor Connie Katelaris about why labelling an individual with a 'cephalosporin allergy' is inaccurate.
Apr 16, 2018 • 12min
E22 – Pharmacovigilance and expedited drug approvals
John Dowden interviews Professor Jennifer Martin about why, when and how adverse drug reactions should be reported.
Apr 4, 2018 • 11min
E21 – The cost of asthma medicines
David Liew interviews Professor Helen Reddel about the cost of asthma inhalers and implications for adherence.
Mar 19, 2018 • 12min
E20 – Prescribing for polymyalgia rheumatica
Dr Andrew Boyden interviews Dr David Liew about the aetiology, pathophysiology and management of polymyalgia rheumatica.
Mar 5, 2018 • 10min
E19 – Adverse effects of sports supplements in men
GP Janine Rowse interviews Dr Sarah Martin about the different products found in sports supplements and their wanted and unwanted effects.
Feb 19, 2018 • 11min
E18 – Drugs affecting milk supply during lactation
Dhineli Perera interviews Dr Treasure McGuire about the drugs that can be used to improve or suppress milk supply.
Feb 5, 2018 • 12min
E17 – An update on the treatment of rosacea
Dr Andrew Boyden interviews dermatologist Dr Margot Whitfeld about the diagnosis and treatment options for the different types of rosacea.
Jan 22, 2018 • 9min
E16 - Changes for codeine
Dr David Liew interviews clinical pharmacologist Darren Roberts about why codeine is being rescheduled to a prescription-only medicine and what the implications are.
